Top 4 Large-Cap Stocks In The Drug Manufacturers-Major Industry With The Highest ROE

Below are the top large-cap drug manufacturers-major stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Eli Lilly and Company LLY is 39.98%. LLY's operating margin for the same period is 29.08%. The trailing-twelve-month return on equity at Astrazeneca PLC AZN is 37.84%. AZN's revenue for the same period is $32.98 billion. The trailing-twelve-month return on equity at Bristol-Myers Squibb Company BMY is 30.70%. BMY's revenue for the same period is $19.69 billion. The trailing-twelve-month return on equity at Johnson & Johnson JNJ is 21.79%. JNJ's profit margin for the same period is 19.77%. Trading Ideas.